Summary & Overview
CPT 83505: Total Hydroxyproline, 24-Hour Urine
CPT code 83505 identifies a quantitative laboratory assay for total hydroxyproline, usually measured in a 24-hour urine specimen to evaluate collagen turnover and bone metabolic activity. Nationally, this specialized biochemical test is relevant for monitoring conditions that affect collagen degradation and bone remodeling, including metabolic bone disease and disorders that alter collagen metabolism. Its use informs clinical decisions about bone activity and disease progression rather than serving as a general screening tool.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, common sites of service, and the role of the assay in diagnostic workflows. The publication summarizes how payers typically position coverage for specialized biochemical assays and provides benchmarking context where available. Topics addressed include clinical indications for ordering the test, typical laboratory workflows, and payer considerations relevant to coverage and claims processing.
This nationally focused summary is intended for clinicians, laboratory directors, and billing professionals who need a clear description of what CPT code 83505 represents, why the assay matters clinically, and what to expect operationally when this test is ordered.
Billing Code Overview
CPT code 83505 measures the total hydroxyproline level, typically performed on a 24-hour urine specimen. The test quantifies hydroxyproline, an amino acid derived from collagen breakdown, and is used to assess collagen turnover and bone metabolic activity.
Service type: Clinical laboratory test — quantitative biochemical assay
Typical site of service: Clinical laboratory or hospital laboratory, using outpatient urine collection
Clinical & Coding Specifications
Clinical Context
A typical patient is a postmenopausal woman or an adult with suspected metabolic bone disease referred for biochemical assessment of bone turnover. The clinician orders 83505 (total hydroxyproline measurement) when there is concern for increased collagen degradation as seen with osteoporosis, Paget disease, hyperparathyroidism, bone metastases, or monitoring response to antiresorptive therapy. The patient collects a 24‑hour urine specimen following lab instructions and returns it to the outpatient laboratory or hospital clinical laboratory. The laboratory analyst receives the specimen, documents completeness of the collection, performs any required specimen processing (aliquoting, centrifugation), and runs the hydroxyproline assay. Results are reported to the ordering provider with reference intervals and interpretation comments as appropriate for assessing collagen turnover and bone activity. Typical sites of service are outpatient laboratory, hospital clinical laboratory, or an ambulatory diagnostic center.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when only the professional component of the test is billed separately from the technical component. |
TC |